MYND Life Sciences (XCNQ:MYND) Net Issuance of Preferred Stock : C$0.00 Mil (TTM As of Jul. 2024)

View and export this data going back to 2021. Start your Free Trial

What is MYND Life Sciences Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

MYND Life Sciences's net issuance of preferred for the three months ended in Jul. 2024 was C$0.00 Mil. The number is 0, which means that MYND Life Sciences has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

MYND Life Sciences's net issuance of preferred for the trailing twelve months (TTM) ended in Jul. 2024 was C$0.00 Mil.

MYND Life Sciences Net Issuance of Preferred Stock Historical Data

The historical data trend for MYND Life Sciences's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MYND Life Sciences Net Issuance of Preferred Stock Chart

MYND Life Sciences Annual Data

Trend

Oct21

Oct22

Oct23

Net Issuance of Preferred Stock

MYND Life Sciences Quarterly Data
	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
Net Issuance of Preferred Stock	Get a 7-Day Free Trial										-	-	-	-	-

MYND Life Sciences Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

MYND Life Sciences Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of MYND Life Sciences's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

MYND Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MYND Life Sciences Inc (XCNQ:MYND) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

MYNDF:USA

Address

105-2248 Elgin Avenue, Port Coquitlam, BC, CAN, V3C 2B2

Website

https://www.myndsciences.com

MYND Life Sciences Inc is a medical biotech drug research and development company. The company is focused on neuro pharmaceutical and novel drug development, diagnostics, and vaccines and is developing new biological entities (NBEs) and new chemical entities (NCEs) and differentiates itself from other (bio)pharmaceutical companies by different molecular concepts for the applications of psilocybin analogs for overcoming diseases.